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Abstract
Two goals have been set for Gambian human African trypanosomiasis (HAT), the first is to
achieve elimination as a public health problem in 90% of foci by 2020, and the second is to
achieve zero transmission globally by 2030. It remains unclear if certain HAT hotspots could
achieve elimination as a public health problem by 2020 and, of greater concern, it appears
that current interventions to control HAT in these areas may not be sufficient to achieve zero
transmission by 2030. A mathematical model of disease dynamics was used to assess the
potential impact of changing the intervention strategy in two high-endemicity health zones of
Kwilu province, Democratic Republic of Congo. Six key strategies and twelve variations
were considered which covered a range of recruitment strategies for screening and vector
control. It was found that effectiveness of HAT screening could be improved by increasing
effort to recruit high-risk groups for screening. Furthermore, seven proposed strategies
which included vector control were predicted to be sufficient to achieve an incidence of less
than 1 reported case per 10,000 people by 2020 in the study region. All vector control strate-
gies simulated reduced transmission enough to meet the 2030 goal, even if vector control
was only moderately effective (60% tsetse population reduction). At this level of control the
full elimination threshold was expected to be met within six years following the start of the
change in strategy and over 6000 additional cases would be averted between 2017 and
2030 compared to current screening alone. It is recommended that a two-pronged strategy
including both enhanced active screening and tsetse control is implemented in this region
and in other persistent HAT foci to ensure the success of the control programme and meet
the 2030 elimination goal for HAT.
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Author Summary
Gambian sleeping sickness is a tsetse-transmitted disease which, without treatment, usu-
ally results in death. Unfortunately no medical prophylaxis exists to prevent infection in
humans but curative medicines and vector control options are available. Recently there
has been a push to reduce disease burden and a target incidence of 1 reported case per
10,000 people per year is hoped to be achieved in 90% of regions by 2020. Subsequently
there is a goal of zero transmission by 2030. Using mathematical modelling, we assessed
how different intervention strategies such as improving screening and treatment or intro-
ducing vector control can help in achieving these goals in a high endemicity setting. Fol-
lowing model simulation, we predict that improving current screening can reduce the
time taken until the elimination targets are met. However it is very unlikely that the
reported case target will by achieved by 2020 without additional vector control. We found
that vector control has great potential to reduce transmission and, even if it is less effective
at reducing tsetse numbers as in other regions, the full elimination goal could still be
achieved by 2030. We recommend that control programmes use a combined medical and
vector control strategy to help combat sleeping sickness.
Introduction
Gambian sleeping sickness (one of the two forms of human African trypanosomiasis, HAT)
has long been a scourge to many in sub-Saharan Africa, with this virulent tsetse-borne disease
persisting in numerous foci despite decades of interventions. In recent years, great improve-
ments to curative drugs and screening programmes have contributed to a substantial decline
in disease incidence [1]. In addition, advances in tsetse control have meant that control pro-
grammes can use strategies with interventions against both the parasite and vector [2, 3].
One such tsetse control method is through the use of insecticidal targets, in particular the
recently developed “tiny target” [2, 4]. In areas which have already implemented vector control
via tiny targets, a sharp decrease in tsetse abundance has been observed; there has been a
reported 80% reduction to tsetse populations in Guinea [3] and 90% reduction in Uganda [2].
To complement regular medical surveillance, such tsetse control has the potential to help push
towards elimination of this disease. In 2012, the World Health Organization (WHO), targeted
Gambian HAT for elimination as a public health problem (defined as less than 1 reported case
per 10,000 per year) in 90% of foci and fewer than 2000 reported cases by 2020. With just over
three years left, many foci are thought to be on track to meet this low level of incidence [1, 5].
However some foci of the Democratic Republic of Congo (DRC) are likely to fall in the 10%
which do not reach this target level. Whilst these regions will probably not stop achievement
of the 2020 goal, which is defined at a global rather than local level, it poses the question of
whether changes to intervention strategy could be sufficient to meet the elimination as a public
health problem threshold by 2020 in these more challenging areas.
A secondary WHO goal is to completely eliminate HAT, with zero transmission of infec-
tion by 2030. Some high-endemicity regions are likely to have transmission remaining at rela-
tively high levels if no change is made to current intervention strategy [6] and they may hinder
achievement of this 2030 goal.
In DRC, the former province of Bandundu accounted for 46% of the total cases of HAT
between 2000–2012 [7], and so this is a critical region in which the battle against HAT must be
won. Using mathematical modelling, a previous study [6] suggested that heterogeneity in risk
and behaviour in the human population is an important driver of disease dynamics in the
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Yasa-Bonga and Mosango health zones of former Bandundu (they are now in the smaller,
newly formed Kwilu province following changes to administrative boundaries). In line with
social science studies which indicate working adults are underrepresented in screening [8],
model comparison of the study indicated that those at highest risk of infection, from highest
exposure to tsetse bites, are also less likely to participate in active screening campaigns.
Screening and treatment of the population was estimated to have decreased the incidence
of new transmissions by over 50% over a 13-year period [6]. It is now crucial to examine quan-
titatively how the intervention strategy may be improved to further reduce transmission in
Yasa-Bonga and Mosango and ensure that the 2030 WHO elimination goal is met.
Intervention strategies
The mainstay of HAT control strategy is medical intervention consisting of either passive or
active detection. Passive detection occurs when infected individuals self-present to medical
facilities following onset of symptoms. Since progression of HAT disease is slow and the initial
stage of infection (stage 1 disease) gives rise to relatively mild symptoms, there is a period of
around 17 months [9] where individuals are unlikely to seek HAT treatment, or, if they do, the
non-specific systems shared with other illnesses including malaria [10] can result in misdiag-
nosis. During stage 2 disease, defined as the time after the parasite has crossed the blood-brain
barrier, patients develop severe symptoms such as behaviour disturbances, lethargy and even-
tually, without treatment, most cases will result in death [11]. After progressing to stage 2
patients will be more likely to present to medical facilities [12, 13].
In contrast, active detection consists of mobile screening teams travelling to villages and
typically testing over 70% of the population. This type of screening can lead to early diagnosis
of HAT infection, thereby reducing patient suffering whilst also preventing those patients con-
tributing towards onwards infection. Between 2000 and 2012, annual screening levels in Yasa-
Bonga and Mosango ranged from 15% up to 53% of the population and had a mean level of
30%. Initially the reported case incidence lay at 26 cases per 10,000 across the two health
zones. In 2009 there was a peak of 40 cases per 10,000, which coincided with the year when
screening was greatest. By 2012 there were slightly less than 10 reported cases per 10,000.
These data are visualised in Rock et al. [6] alongside model fitting results which indicate that
underlying transmission incidence is likely to have reduced by 52–53% between 1998 and
2012. Demographic data for the region is sparse; people tend to live in small villages and there
is limited information on these populations. Consequently, aggregate data is used in this
analysis.
Following case confirmation, one of two treatments is administered; pentamindine for
stage 1 disease and nifurtimox and eflorithine combination treatment (NECT) for stage 2.
During treatments patients are hospitalised and subsequently are advised to rest at home. The
model presented uses a mean duration of 6 months from detection to a return to normal activ-
ities and therefore tsetse exposure and the chance to be re-infected by subsequent tsetse bites.
During active screening, the mobile teams attempt to recruit as many of the population as
possible, but often certain groups are unrepresented in testing; in particular, adult males, who
may work away from the village, are thought to be consistently missed [8]. Another heteroge-
neity in the human population is exposure to tsetse bites, with individuals spending time in
the forested or riverine areas where tsetse concentrate receiving the most bites [14]. A previous
modelling study indicated that there was evidence that the highly exposed individuals are also
the group which do not participate in active screening [6]. Identifying this key component in
transmission and treatment of HAT infection provides an opportunity to improve current
active detection strategy by placing emphasis on recruiting individuals in screening who have
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not previously participated. A similar approach has recently been suggested by Stone et al.
[15], who deduced that reaching the high-risk individuals should be prioritised to control dis-
ease effectively.
Aside from medical intervention, methods to control the tsetse population are available.
These include the use of insecticide-treated baits to lure and kill tsetse, or widespread applica-
tion of insecticides through aerial or ground spraying [16, 17]. Different methods have been
shown to be more or less effective in different geographical areas due to factors including the
landscape, animal abundance and tsetse species. Unlike other disease vectors such as the mos-
quito, the unique reproductive biology of tsetse means that it is relatively easy to cause large
drops in population sizes by raising mortality just a few percent [18]. In this study the focus is
placed on use of tiny targets, which is one method of tsetse control suited to deployment in
these health zones. Tiny targets comprise small (0.25 x 0.5 m) panels of insecticide-impreg-
nated blue fabric and black netting which are deployed in the riverine habitats where tsetse
vectors of Gambian HAT concentrate. Tsetse are attracted to the target, contact it and, in so
doing, pick up a lethal dose of insecticide. Trials in Guinea [3], Kenya and Uganda [2] have
shown that deployment of tiny targets can reduce densities of tsetse by 70% to>90%. The tar-
gets are cheap (*US$ 1/target) and easy to deploy, hence control of the tsetse population can
be achieved at US$ 84/km2 [19]. Shaw et al. have assessed the relative costs of other methods
(e.g., ground and aerial spraying at US$ 380/km2, traps at US$ 283/km2) [20] and shown how
inexpensive tiny targets are by comparison. Insecticide-treated cattle is also a cheap method
(US$ 30/km2) [20–22] but this is not possible in areas such as Yasa-Bonga or Mosango where
cattle are absent or sparse (<10 animals/km2) [23–25].
Measuring elimination of HAT
In 2012 the WHO set ambitious targets for 10 neglected tropical diseases (NTDs) to be
achieved by 2020. For Gambian HAT, this goal is to reach “elimination as a public health prob-
lem” which is defined as being less than 1 case per 10,000 people per year in 90% of HAT foci
[26]. There is also a global target of fewer than 2000 reported cases per year by 2020. These
WHO targets are based upon observed case reporting as this has previously been the only
available measure of global or country-level burden of disease in humans. There are, however,
caveats in using reported case incidence. Firstly there is thought to be high levels of underre-
porting, with the WHO previously estimating this at around 65–75% [27, 28]. Secondly, and
crucially, the active case detection and reporting is dependent upon both the accuracy of the
diagnostic algorithm and the percentage of the population screened.
Rock et al. [6] recently proposed an alternative method for evaluating transmission, which
is less sensitive to underreporting, screening levels and test sensitivity. This provides an esti-
mate of the incidence of new infections, which can be inferred from reported case data and
active screening levels using mathematical modelling. It should be noted that underlying inci-
dence is not the target in the WHO 2020 goals, and that this previous publication did not
make the distinction clear.
As might be expected, using observed case reporting, the incidence of HAT infection
appears to increase during periods with high levels of screening; for instance high reported
incidence was observed in 2009 in Yasa-Bonga and Mosango when the maximum screening
(53% of the population) was achieved. Likewise, if improvements are made to combat underre-
porting of disease, such as using rapid diagnostic tests as part of passive screening in rural loca-
tions, this will also result in an increase in reported cases. These two improvements (increased
active screening and decreased underreporting) will support a reduction in disease transmis-
sion, yet this will not be reflected in reported incidence. The proposed measure of new
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infection incidence is able to capture the positive impact of such improvements as new infec-
tions (transmission) will decrease with the boost in case detection.
Models for prediction
Mathematical modelling enables the prediction of the possible impact of a range of interven-
tion strategies upon human disease, in addition to providing estimates of underlying transmis-
sion and new infection incidence which cannot be directly observed. Using these metrics,
predictions can be made for the years in which elimination and elimination as a public health
problem can be achieved. Additionally, the number of new cases averted compared to a base-
line strategy can be computed.
Previous work by Rock et al. [6] which fitted a mathematical model for HAT to human case
data from Yasa-Bonga and Mosango has provided estimates for when the incidence of new
infections is expected to fall below a threshold of less than 1 new transmission per 10,000 peo-
ple per year under current interventions. In this region, active screening formed the main
component of the intervention strategy and no large-scale tsetse control had yet been imple-
mented. This analysis concluded that using screening alone would not result in swift reduction
of infection, and new transmissions would not be likely to drop below 1 per 10,000 until 2059–
2091. Consequently these health zones may present problems in the achievement of the 2030
goal of zero transmission.
This article now presents the possible impact of tsetse control, particularly via the use of
tiny targets, and improved active screening campaigns in these high endemicity health zones.
Methods
Modelling control of tsetse
Modelling the impact of tiny targets on tsetse populations is non-trivial. Rather than simply
increasing the mortality of flies, the targets affect flies during the host-seeking phase of their
feeding cycle. This has knock-on effects for reproduction, particularly as female tsetse carry
their offspring one at a time until ready to pupate.
In this study a mathematical model was developed (for more information, see S1 Model
formulation and analysis) which incorporates the following biological aspects of tsetse biology:
• Gamma distributed (n = 3) feeding cycles, with a mean time between bites of 3 days.
• Age- and gender-dependent mortality, parameterised using the functional form given by
Hargrove [29].
• An explicit pupal stage where the rate of new pupae being deposited is dependent on the
number of adult females taking their third feed since they matured or deposited their last off-
spring. This is to account for the pregnancy period.
• Density dependent tsetse population with growth limited by factors such as parasitism and/
or predation on pupae [30].
• Chance of having a lethal contact with a tiny target during feeding phase with a probability
of dying dependent upon how long the target was placed in the field. Targets efficacy was
assumed to remain high for the first 3 months, followed by a decline due to loss of insecti-
cide. This is similar to the approach taken by other authors [5, 31], but here a sigmoidal func-
tion is chosen rather than constant efficacy followed by a linear decline.
Whilst incorporating so much biological complexity results in a more complex mathemati-
cal model, the majority of the necessary parameters have been empirically estimated and so the
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adult emergence rate, and consequently, the “bounce-back” time following target removal,
which are unknown can be found from these other parameters. It is also noted in the context
of this specific study, that cessation of intervention is not considered, and so the exact mecha-
nism of the “bounce-back” (i.e. population regrowth versus invasion from neighbouring
regions) is of less importance.
A simpler version of this model without tsetse senescence is also used. This version still
retains an explicit pupal stage with density dependent mortality and target-dependent deaths
only occur with feeding, but the biting pattern is exponentially distributed rather than gamma
distributed (see S1 Model formulation and analysis). The simpler version can be parameterised
to give similar dynamics (see Fig 1 for a comparison between the structured and unstructured
models). It is this simpler model which is then used within a tsetse-host HAT infection model
to simulate the impact of tsetse control on human disease dynamics.
Improvements to screening
The model for tsetse population dynamics in areas where targets are present (described above)
was taken in conjunction with an existing model which included active and passive detection
and treatment [6]. This new extension allowed the projection of future HAT incidence under
various strategies in which existing active screening was combined with vector control. Previ-
ous model fitting and selection to observed HAT dynamics in Yasa-Bonga and Mosango
between 2000–2012 using the deviance information criterion (DIC) could not conclusively
support or rule out the possibility of an animal reservoir in the transmission cycle, and so vari-
ants both with and without animal transmission were included here in the analysis (Models 4
and 7). The analysis in the previous article found that the best fitting models had two distinct
human subgroups, the first was at low-risk from receiving tsetse bites and participated ran-
domly in active screening, whereas the second were both at high-risk and had systematic non-
participation.
Fig 1. Complex and simple tsetse demography models. The figures compare the complex age- and gender-dependent tsetse
model to a simpler version where there has been (A) 1 year and (B) 3 years vector control with 6-monthly target replacement. In this
example it is assumed that after one year of targets the population has decreased by 90%. The deposit rate of pupae in the simpler
model is chosen so that the “bounce-back” dynamics of the two models are comparable.
doi:10.1371/journal.pntd.0005162.g001
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The analysis presented here assessed the impact of changing active screening strategy to
focus on being able to recruit high-risk individuals to the screening programme. This was
done so that three active screening strategies could be evaluated: (i) only low-risk individuals
are actively screened (as in [6]) (ii) both low- and high-risk individuals had the same probabil-
ity of participating in screening (iii) the high-risk population were targeted for screening with
the remaining screening occurring randomly from the low-risk population. It is assumed that
this change in screening occurs from 2017 onwards.
Combined strategies
The key strategies consisted of:
• Actively screening 30% of the human population from 2017 onwards, this corresponds with
the mean level achieved between 2000 and 2012 in the region [1, 32]. For the years 2013–
2015, the level of active screening is known (although the number of cases is not).
• Recruiting people to active screening with either (a) low-risk only (the current situation), (b)
both low- and high-risk equally, or (c) all those at high-risk and the remainder at low-risk of
exposure to tsetse bites.
• Implementing (a) no vector control, or (b) vector control beginning in 2017. For the strate-
gies with tsetse control, 60% reduction in tsetse density after 1 year was assumed (described
here as moderately effective).
These six key strategies are given in Table 1. In addition to these key strategies, variations
upon these include:
• higher screening coverage at the maximum level (53%) achieved between 2000–2012
• vector control beginning in 2018
• 90% reduction in tsetse density after 1 year (described here as highly effective).
These additional interventions, resulting in 18 different strategies are given in Table S3 in
S1 Model formulation and analysis.
As mentioned previously, the specificity of diagnostics will impact the reported number of
cases. At present the diagnostic algorithm consisting of the card agglutination test for trypano-
somes (CATT) followed by subsequent parasitological confirmation has a high, but imperfect
Table 1. Key intervention strategies under consideration.
Recruited to screening Tsetse reduction
Strategy name Low-risk only Equal High-risk first 0% 60%
Screen low-risk X X
Screen equally X X
Screen high-risk X X
Screen low-risk + VC X X
Screen equally + VC X X
Screen high-risk + VC X X
This table presents the proposed screening and vector control strategies. For strategies with vector control it is assumed that initial target deployment
begins in 2017 and achieves 60% reduction in tsetse density after one year. The amount of annual active screening assumed is 29.9%, which is the mean
level achieved between 2000–2012. Other variations on these strategies are presented in the SI.
doi:10.1371/journal.pntd.0005162.t001
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specificity, with the value here taken to be 99.9% [33]. Such a specificity would result in 5
detections per 10,000 uninfected people if 50% of the population were screened and so it is
likely that in this setting some reported cases are false positive detections. However as the
number of detections fall, suspected cases are more carefully scrutinised and other methods
can be utilised to increase specificity to 100%.
To account for this improvement in case detection specificity as the reported active and pas-
sive cases decline, the model uses the assumption that specificity switches from 99.9% to 100%
at some critical threshold. Ultimately this threshold could be chosen in a variety of different
ways; here it is taken to be once there are fewer than 2 reported cases per 10,000 above the
expected incidence of false positives based on the the level of screening. For example, if 40% of
the population were screened in 2019, then the expected incidence of false positives (for an
uninfected population) would be 4 per 10,000. Therefore if there were fewer than 6 reported
cases per 10,000 in 2019, this would fall below the threshold and so in 2020 the specificity
would be increased to 100%. For Yasa-Bonga and Mosango, if there were a similar incidence
(6 cases per 10,000 found under 99.9% specificity testing) and also 40% screening in 2020 this
would equate to approximately 70 HAT suspects which required more rigorous testing.
The full ODE model equations and fixed parameters, such as population size, tsetse bite rates
and disease durations used for this analysis are given in S1 Model formulation and analysis. A
compartmental model diagram can also be found in S1 Model formulation and analysis. Param-
eters which could not easily be established from empirical data, included: the tsetse to human
ratio, relative exposure of tsetse bites for different groups of the population and the level of
underreporting. These were previously fitted [6] and the posterior parameters distributions
found in that study were used here to generate samples for the intervention evaluation. As with
the previous analysis, the performed simulations computed the continuous underlying host-
vector disease dynamics which was then converted to an annual reporting incidence of passive
and active detections, and new infections. The new infection incidence in humans was com-
puted for the strategies under consideration, allowing the expected year of reaching less than 1
new infection per 100,000 people to be estimated. As this threshold is extremely low, equating
to fewer than 3 cases in total across both health zones, and so is used as a proxy for full elimina-
tion and achievement of the 2030 goal. Additionally, the projected reported number of cases
was compared with the elimination as a public health problem threshold to identify whether
these health zones could achieve this goal for the different strategies.
Results
Figs 2 and 3 give the elimination year results of simulations under each of the key strategies.
Further results using variations on key strategies are shown in Figs. S5 and S6 and Tables S4
and S5 in S1 Model formulation and analysis. The total number of cases averted between 2017
(the start of new strategies) and 2030 compared to screening low-risk people alone is presented
in Table S6 in S1 Model formulation and analysis. It is noted that the inclusion of animal reser-
voirs made little difference to the results with 95% credible intervals for models with and with-
out a non-human animal reservoir largely overlapping.
Impact of intervention strategies on transmission
It is very unlikely that the 2030 full elimination target will be met by continuing with strategies
which screen only low-risk members of the population and with no vector control (Fig 2). The
predicted elimination year is 2236 for mean screening, and 2121 for maximum screening. This
demonstrates how the current strategy is unlikely to impact HAT transmission sufficiently to
reach full elimination by 2030.
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However, in the absence of vector control, improving screening so that all people are
screened equally has a huge impact on the expected year in which the transmission will drop
below 1 per 100,000. With maximum screening levels the time is reduced by 94 years (in the
year 2027) and with mean screening levels, by 198 years (in the year 2039).
Targeting high-risk people in recruitment, so that all high-risk people are screened and the
remaining screened are low-risk, reduces the time to the target transmission threshold even
further. Even a modest screening level (the mean achieved between 2000–2012) would likely
be sufficient to meet the 2030 elimination target.
Fig 2. Impact of possible strategies on elimination. The figure shows the predicted year in which transmission drops below 1
case per 100,000 under the six different strategies and compares this to the target year of 2030.
doi:10.1371/journal.pntd.0005162.g002
Fig 3. Impact of possible strategies on elimination as a public health problem. The figure shows the predicted year in which
the reported cases drop below 1 case per 10,000 under the six different strategies. The results are compared to the year 2020 to
see if it is possible that these regions could be amongst the foci that achieve the elimination as a public health problem target within
this timeframe.
doi:10.1371/journal.pntd.0005162.g003
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With large-scale reductions in vector density of either 60% or 90% there was a dramatic
reduction upon transmission of disease and, under any of the strategies (7–18), the 2030 elimi-
nation goal was predicted to be met in or before 2024. If a modest 60% reduction was achieved
then changing screening strategy meant that the elimination year was bought further forwards
and was dependent upon the level and type of recruitment used for active screening. Changing
screening from low-risk only to everyone equally bought the elimination date forward by
around two years. In simulations of vector control with a 90% reduction in tsetse density
across the area, changing screening strategy from current (low-risk only) to strategies which
screen all people equally or high-risk first did not substantially change the elimination year; in
both cases this occurred after just 1–2 years after tiny targets deployment. With this vector
reduction there are only small differences between using mean and maximum screening levels.
Finally, with a combination of high-efficacy vector control and recruiting all high-risk individ-
uals to screening, the new infection incidence could be reduced to below the elimination
threshold after just one year of implementation.
The number of cases averted (Table S6 in S1 Model formulation and analysis) follows the
same trend; changes that make the most difference are either recruiting some high-risk groups
to active screening and/or introducing vector control. Whilst increasing the percentage tsetse
reduction from 60% to 90% could make almost four years difference to the full elimination
year if only low-risk people are screened, there is a relatively minor increase in the number of
cases averted if high rather than moderate tsetse control is achieved. All vector control strate-
gies are expected to result in over 6200 averted cases compared to mean screening alone and
equal or high-risk screening without vector control is predicted to avert over 4900 cases. By
comparison, increasing the level of screening from 30% to 53% is expected to only avert 1410
cases.
Impact of intervention strategies on reported cases
Qualitatively similar results are obtained for the elimination as a public health problem year,
which is when reported cases reached less than 1 case per 10,000 (Fig 3). Under current strate-
gies with either mean or maximum screening (strategies 1 and 2), there was a substantial delay
to the time elimination as a public health problem was achieved.
Strategies which improved screening but remained without vector control (Strategies 3–6)
greatly reduced the time until elimination as a public health problem but failed to meet it by
2020. All strategies with vector control (7–18) were predicted to meet the elimination as a pub-
lic health problem threshold by 2022 and 7 vector control strategies (all starting in 2017) were
found to be sufficient to achieve the target in 2020 if 90% vector control was achieved.
Relationship between transmission and reporting
There is a complex relationship between transmission and reporting. There is the trend that
the strategies that give the best (or worst) outcomes for full elimination are the same as those
that give the best (or worst) results for elimination as a public health problem. In the absence
of vector control, elimination as a public health problem is predicted to be achieved before full
elimination as naturally expected. In contrast, for many strategies with vector control, trans-
mission will fall below 1 new transmission per 100,000 in advance of reported cases dropping
below 1 case per 10,000. For these strategies, the level of vector control achieved was sufficient
to halt transmission quickly and whilst there was a consequent rapid drop in new cases, previ-
ously infected individuals would still remain infected until they were detected and treated,
which could take several years given the disease progression and screening intensity for HAT.
Two examples of reported cases compared to transmission are shown in Fig 4.
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Fig 4. Examples of the relationship between transmission and reporting. The figures present two example
simulations showing transmission (green lines) and reporting (black lines). Total reporting consists of both active and
passive detections. In the case where transmission is reduced slowly through detection and treatment alone (Strategy
2), transmission remains above the reported cases (since not all the population are screened and there is also
underreporting). Conversely, with high efficacy vector control (Strategy 14), transmission drops sharply due to the
sudden reduction in tsetse numbers, however the previously infected individuals will continue to be detected both in
active and passive screening for several years.
doi:10.1371/journal.pntd.0005162.g004
Predicting the Impact of Intervention Strategies for Sleeping Sickness in DRC
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005162 January 5, 2017 11 / 17
Discussion
Modelling predicts that whilst the increasing the level of active screening achieved and improv-
ing efficacy of vector control contribute to a decrease in transmission and time to elimination,
most gains are made either by (a) improving recruitment high-risk people to screening or, (b)
adding some vector control. The results here highlight the great potential for vector control in
DRC and these mirror the type of outcomes which have been observed in other areas; the
Boffa area of Guinea currently appears on track to meet the target of less than 1 case per 10,000
[5] following introduction of vector control strategies.
This study does not consider the financial implications of different strategies, only projected
timeline until the elimination target is met. However, in another modelling study which does
consider cost-effectiveness of vector control and medical intervention [31], strategies includ-
ing vector control are found to be the most cost-effective—due to the low cost of tiny targets.
The dramatic results for vector control presented here suggest that the reduction in the length
of time for which interventions are needed may mean that strategies with tsetse intervention
are more cost-effective, but further work is needed to determine this explicitly. There will be a
balance between the costs of tsetse control and its impact; for example is achieving 90% vector
control through six-monthly target deployment more or less cost-effective than a lower level of
tsetse control achieved through annual deployment? It would also be beneficial to consider the
cost-effectiveness of other methods of vector control. Studies conducted on small islands in
Lake Victoria, Kenya, targets deployed at 50–100 m intervals along the shore were estimated to
impose a daily mortality of 3–6% and targets deployed at 50 m intervals along rivers in the
West Nile region of Uganda, giving overall densities of *6 targets/km2 in, were estimated to
impose a daily mortality of 4%. Costs of deploying targets at densities of 6 targets/km2 to
impose a daily mortality of 4% were estimated at USD 84/km2 [2, 19] which gives some indica-
tion of the potential costs associated with adding a tiny target strategy to current medical
interventions.
Another possible change to intervention strategy is to reduce the high level of underreport-
ing by improving passive case detection. In some regions including Chad [34], Uganda [35]
and the Kongo Central (formally Bas-Congo) province of DRC [36], efforts have already been
made to increase access to HAT diagnostics by ensuring more local medical facilities carry
rapid diagnostic tests (RDTs). Due to uncertainty in the way such schemes may affect passive
reporting this was not incorporated in the study presented here, but the doubtless benefits of
improving access to HAT diagnosis should not be overlooked.
In the future, new developments in HAT drugs could change the way in which interven-
tions are carried out. Two promising oral drugs, fexinidazole and oxaborole, are in the pipeline
with the aim of improving the administration of HAT treatment [37]. It is hoped that both
drugs will be stage-independent, removing the need for a lumbar puncture in the diagnostic
algorithm, and ideally that they have a suitable safety profile which would allow for much sim-
pler test and treat strategy, potentially just using an RDT [38]. Such a strategy could result in
much faster time to treatment by reducing the time spent performing multiple diagnostic tests
in the field for active screening, or finding health facilities with the ability to perform the nec-
essary tests to confirm a HAT case for passive detection. Finally, drugs which could be admin-
istered on an outpatient basis could encourage screening uptake as hospital admission has
previously been identified as one barrier [39].
The structure of the model presented here and in Rock et al. [6] captures key components
of our current understanding of HAT transmission dynamics with unknown parameters that
can be inferred from the available data. This type of model structure is relatively flexible to
new additions, such as the tsetse control part of the model that was developed for this study. In
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future work it will also be necessary for other elements to be incorporated as new technologies
alter the diagnostic and treatment options available.
This modelling work necessarily makes many assumptions and these should be taken into
consideration with the results presented here. Firstly, this model has not been validated to
additional data from these health zones. Once later data (e.g. 2013-2015) becomes available,
the predictive ability of the model in this region can be assessed by comparing predicted and
actual reported cases. Secondly, the effectiveness of vector control in this region is yet to be
assessed and the level and type of screening strategy achieved is unlikely to exactly match those
described. Despite this, the selected strategies should be representative of the type of results
that could be anticipated.
Additionally, there are spatial heterogeneities which have not been taken into account. For
example, it is more likely that people living near larger settlements take part in screening and
that there will be variation in tsetse abundance across different regions. Instead a homoge-
neous assumption was made, due to lack of knowledge on population movements and timing
of screening in different areas. The resolution used in this analysis by utilising aggregate data is
intended to provide a policy guide to measure the overall progress towards the elimination
goals in these areas, rather than make higher-resolution intervention planning decisions, for
example, where to place tiny targets or which villages to screen. Modelling could certainly pro-
vide more detailed evaluations of that type as well as evaluate how spatial heterogeneities could
influence elimination but novel stochastic models with a much greater degree of complexity
would be required.
The data provided were based on annual reporting and so active screening was assumed
to take place at the beginning of each year. This was the most reasonable parsimonious
assumption given the data. Likewise the timing of the initial vector intervention was taken
to coincide with active screening. It was assumed that all targets are deployed rapidly,
although it is acknowledged here that it could take several weeks to cover the health zones.
This could impact predicted outcomes, but since the tsetse density is matched to reductions
similar to those observed in the field at 1 year post-intervention. It is believed that any
initial discrepancies will not greatly affect the model outcomes which are presented yearly,
although it is acknowledged this could impact upon accuracy of predictions, particularly in
the short-term. Improved temporal resolution of, say, month of active and passive detec-
tions, the length of time needed to deploy targets, and the timing between screening and tar-
get placement, would help to give greater confidence in the estimates, particularly in the
short-term. Nonetheless it is thought that long-term predictions will remain qualitatively
unchanged.
Under this model, an assumption was made that stage 1 individuals would not be detected
through the passive system. This modelling decision was taken as most passive detections are
made in stage 2, and the data did not contain staging information to infer the passive detection
rate of stage 1 cases. In future work, the addition of stage 1 passive detection will become more
important as the consequences of improving the passive surveillance system—through increas-
ing the number of health facilities with HAT diagnostics—will be examined.
In this analysis it was assumed that the current diagnostic algorithm specificity could
increase from 99.9% to 100% following extra validation of cases at very low incidence. The try-
panolysis test may provide one way to achieve 100% specificity, although the test currently
requires samples to be sent away for analysis, meaning that it has primarily been used during
field trials rather than as standard procedure [40]. Improved specificity explains how other
regions with active detection campaigns can report no cases [1]. On-going work fitting the
model to data from other regions of DRC shows that in many low-endemicity areas 100%
specificity is indeed a better fit to the data than 99.9%.
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Under the model this improvement to screening is assumed to happen once incidence
reaches low levels. For simplicity and due to lack of available data, we have assumed a step-
change for this improvement; a more gradual change would likely delay elimination as a public
health problem by a few years. It is stressed that, without some change to specificity of the diag-
nostic algorithm, it would be unlikely to achieve less than 1 reported case per 10,000 whilst
active screening continues at moderate levels, due to the number of false positives detected.
Imperfect specificity would not impact on the transmission dynamics themselves and so full
elimination predictions would not change.
Yasa-Bonga and Mosango represent just two health zones from former Bandundu province,
therefore this study cannot explicitly address the achievability of the 2020 goals as these are
defined at a global rather than local level. In future analysis it will be important to perform sim-
ilar modelling studies to assess the impact of alternative intervention across the whole of this
province which has a comparatively high HAT burden, and also in other regions in which
HAT infection persists. The study here utilised previous model fitting of the effective tsetse-
host ratio in Yasa-Bonga and Mosango to predict the impact of moderate and effective tsetse
control for this area. It should be noted that the pre-intervention host-vector ratio and other
parameters associated with the basic reproductive ratio will be an important factor in predic-
tion for other areas.
Other future studies should consider the timescale for which interventions must be imple-
mented before they can be lifted without recrudescence occurring. Whilst the threshold of less
than 1 case per 100,000 is used as a proxy for full elimination, future elimination/recrudes-
cence studies will likely utilise stochastic models which can incorporate chance events that
become important at low numbers of infections. This type of study is also made more complex
by having to consider the mechanisms by which tsetse populations may reestablish following
removal of tiny targets. For example if there are no flies left in one area, reinvasion from neigh-
bouring regions which did not use tsetse control will be the only way for tsetse populations to
recover. If tsetse control merely suppressed the number of flies, bounce-back will be due to a
combination of new births and importations. Once appropriate reinvasion models have
been formulated, they could also examine the impact of tsetse control on a small scale, which
could be useful in the case that some regions achieve elimination whilst others still have HAT
infection.
Finally, this study presents a range of intervention strategies which are deemed to be possi-
ble to achieve, but some will inevitably be easier to implement than others. In particular it is
not clear exactly how the posed improvements to screening may be achieved. More high-risk
people (those receiving the most tsetse bites) could potentially be recruited by moving the loca-
tions of screenings closer to their daily activities, or altering the time of screening so that they
are not away from the village. Mpanya et al. [13] suggest that education is essential to improve
screening participation as there are often taboos surrounding diagnosis and misinformation
about treatment regimes. This may be one focus of improving screening participation and it
will be vital to learn from social science to understand how best this issue can be tackled.
Undeniably, one of the reasons these regions have not previous implemented vector control is
the complex task of placing targets in such a remote and rural locations and this challenge
should not be disregarded. Strategy planning should find the best way to combine medical and
vector interventions taking into account intervention effectiveness, cost and practicality.
Supporting Information
S1 Model formulation and analysis. Model formulation and analysis. Detailed model
description and equations for vector control and HAT infection dynamics are given.
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Additional results are presented.
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S1 Model Code. Model code. MATLAB code used for the forward projections of HAT infec-
tion.
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